Petiatric Oncology

i was the lead market planner for new oncology products for the us. Market, which is basically to try and think about how medicines that could potentially work at a phase one trial should be launched in the us. And then i joined a venture capital fund, which is canan, where we invest in small businesses, small businesses that are looking for new pharmoceuticals. When when you think about every place that this medicine could help patients, you realize it's actually a bigger opportunity.